Profile for Israel Patent: 241452
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Israel Patent: 241452
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Jul 26, 2034 | Chimerix | MODEYSO | dordaviprone hydrochloride |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
